Inflammatory mediators implicated in MS pathogenesis, such as interleukins and tumor necrosis factor-alpha, have been identified in the renal tissues of individuals with renal disease.[13] This parallel inflammatory milieu may contribute to the development or exacerbation of renal dysfunction in MS patients. The gene discussed is TNF; the disease is myeloid sarcoma.